Novartis AG (NVS): Price and Financial Metrics

NVS POWR Grades

• Stability is the dimension where NVS ranks best; there it ranks ahead of 98.18% of US stocks.
• NVS's strongest trending metric is Quality; it's been moving down over the last 179 days.
• NVS ranks lowest in Momentum; there it ranks in the 17th percentile.

NVS Stock Summary

• With a market capitalization of $177,268,700,000, NOVARTIS AG has a greater market value than 99.11% of US stocks.
• Over the past twelve months, NVS has reported earnings growth of 119.03%, putting it ahead of 87.05% of US stocks in our set.
• In terms of volatility of its share price, NVS is more volatile than only 1.42% of stocks we're observing.
• Stocks that are quantitatively similar to NVS, based on their financial statements, market capitalization, and price volatility, are AZN, CSCO, TXN, BMY, and RTX.
• Visit NVS's SEC page to see the company's official filings. To visit the company's web site, go to www.novartis.com.

NVS Valuation Summary

• NVS's price/earnings ratio is 7.3; this is 62.76% lower than that of the median Healthcare stock.
• Over the past 243 months, NVS's price/sales ratio has gone down 2.8.

Below are key valuation metrics over time for NVS.

NVS Growth Metrics

Its 3 year cash and equivalents growth rate is now at 103.5%.
• Its 2 year revenue growth rate is now at 6.14%.
• Its year over year net income to common stockholders growth rate is now at 204.01%.

Over the past 70 months, NVS's revenue has gone up $3,154,000,000.

The table below shows NVS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	52,788	14,213	22,982
2022-03-31	52,997	14,590	24,184
2021-12-31	52,877	15,071	24,021
2021-09-30	52,385	15,192	9,807
2021-06-30	51,556	13,423	8,984
2021-03-31	49,884	13,252	7,955

NVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NVS has a Quality Grade of B, ranking ahead of 86.01% of graded US stocks.
• NVS's asset turnover comes in at 0.42 -- ranking 108th of 682 Pharmaceutical Products stocks.
• GHSI, KALA, and ADAP are the stocks whose asset turnover ratios are most correlated with NVS.

The table below shows NVS's key quality metrics over time.